Trulicity in Ontario: Once-Weekly Dulaglutide for Type 2 Diabetes From Ontario Physicians
Trulicity (dulaglutide) is a once-weekly injectable GLP-1 receptor agonist that Health Canada has approved to help adults with type 2 diabetes improve blood-sugar control, and to reduce the risk of major cardiovascular events in adults with type 2 diabetes. TelePlus Care connects patients across Ontario with a licensed doctor for a secure virtual assessment, a review of your recent bloodwork, and — when clinically appropriate — a prescription you fill at any pharmacy in the province, whether you live in the Greater Toronto Area, Ottawa, Hamilton, London, Windsor, Kingston, Sudbury, Thunder Bay, or a smaller community in between. From a Shoppers Drug Mart downtown to a Rexall, a Loblaw or Sobeys pharmacy, or a Costco pharmacy in the suburbs, you choose where to fill your prescription.
Book Your Appointment Now
Trulicity (dulaglutide) is a once-weekly GLP-1 injection approved by Health Canada for type 2 diabetes blood-sugar control and to reduce cardiovascular risk in adults with type 2 diabetes. It is prescription-only and not approved for weight loss in Canada. TelePlus Care offers Ontario patients virtual visits with a licensed doctor and a prescription you fill at any pharmacy in the province. A licensed doctor reviews your intake before the visit and explains the safest next step.
- Trulicity is the brand name for dulaglutide, a once-weekly injectable GLP-1 receptor agonist.
- Health Canada has approved Trulicity for the management of type 2 diabetes (glycemic control) in adults.
- It is also indicated to reduce the risk of major cardiovascular events in adults with type 2 diabetes.
- Trulicity requires a prescription after a clinical assessment; it is not a controlled substance and is not approved for weight loss in Canada.
Clinical content is reviewed for accuracy and scope. TelePlus Care appointments proceed only when clinically appropriate after a real assessment, and the doctor will explain the next step if virtual care is not the right fit.
What Is Trulicity and How Does Dulaglutide Work?
Trulicity contains dulaglutide, a GLP-1 (glucagon-like peptide-1) receptor agonist delivered once weekly by a single-use pre-filled pen. By mimicking the body's own GLP-1 hormone, it prompts the pancreas to release insulin when blood sugar is high, lowers the glucose the liver produces, and slows the rate at which the stomach empties. Because this action is glucose-dependent, Trulicity used on its own carries a low risk of low blood sugar. For Ontario adults living with type 2 diabetes, it offers a convenient weekly injection that most patients self-administer at home rather than a daily tablet or injection. Some people notice modest weight reduction as a secondary effect, but Trulicity is not approved or marketed in Canada as a weight-loss treatment.
Who May Be a Candidate for Trulicity in Ontario?
Trulicity is prescribed for adults with type 2 diabetes when blood-sugar targets are not met with lifestyle measures and first-line therapy, or when cardiovascular risk reduction is a goal. A licensed doctor will confirm suitability during the virtual visit.
- Adults with confirmed type 2 diabetes who need additional blood-sugar control.
- Patients whose blood sugar is not adequately controlled on metformin or lifestyle measures alone.
- Adults with type 2 diabetes who also have established cardiovascular disease or elevated cardiovascular risk.
- No personal or family history of medullary thyroid carcinoma or MEN 2 syndrome.
- No history of pancreatitis.
- Not currently pregnant or breastfeeding; discuss family planning with your doctor.
- Trulicity is for type 2 diabetes — it is not approved for type 1 diabetes, diabetic ketoacidosis, or as a weight-loss treatment in Canada.
The Virtual Consultation Process at TelePlus Care
Patients across Ontario complete the assessment virtually with a licensed doctor. Each prescription is documented and shared with your family doctor on request. We don't dispense medication — we issue prescriptions you fill at any pharmacy in Ontario.
- Step 1: Book online — most Ontario patients secure a same-day or next-business-day appointment.
- Step 2: Complete an intake form covering your diabetes history, current medications, and any heart or kidney conditions.
- Step 3: Secure video consultation (15-25 minutes) with your licensed doctor.
- Step 4: Bloodwork review or a new requisition through a local laboratory if your labs are older than 12 months.
- Step 5: If appropriate, a prescription is issued for any Ontario pharmacy. Your doctor will explain the once-weekly injection and how to use the pen.
- Step 6: Structured follow-ups to review blood-sugar control, tolerability, and progress.
Bloodwork and Monitoring Before Starting Trulicity
Recent metabolic and organ-function labs help your doctor confirm the diagnosis, set a baseline, and prescribe safely. LifeLabs and Dynacare collection sites operate across Ontario, and your doctor can send a requisition to a location convenient for you.
- HbA1c — confirms diabetes control and provides a baseline for monitoring.
- Fasting plasma glucose.
- Kidney function — eGFR and serum creatinine.
- Liver enzymes — ALT and AST.
- Lipid profile — total cholesterol, LDL, HDL, triglycerides.
- TSH when clinically indicated.
- Pregnancy test for women of reproductive age where appropriate.
Side Effects of Trulicity
Trulicity shares the GLP-1 side-effect profile, with most effects appearing early and easing within the first weeks as your body adjusts. Most are gastrointestinal and mild to moderate.
- Nausea — most common, especially when starting or increasing the dose.
- Diarrhea or constipation.
- Vomiting or indigestion.
- Decreased appetite.
- Injection site reactions — minor redness or itching.
- Hypoglycemia risk increases if combined with insulin or sulfonylureas.
- Rare: pancreatitis — severe abdominal pain radiating to the back; seek urgent care at your nearest hospital emergency department.
- Rare: gallbladder problems including gallstones.
Trulicity Compared to Other GLP-1 Therapies
Several GLP-1 receptor agonists are used for type 2 diabetes in Canada. Your doctor will help you weigh convenience, tolerability, cardiovascular benefit, and access.
- Trulicity (dulaglutide) — once-weekly injection with a ready-to-use pen; indicated for blood-sugar control and cardiovascular risk reduction in type 2 diabetes.
- Ozempic (semaglutide) — once-weekly injection, also used for type 2 diabetes.
- Rybelsus (semaglutide) — a daily oral GLP-1 tablet option for type 2 diabetes.
- Victoza (liraglutide) — a daily GLP-1 injection.
- Choice depends on your diabetes profile, other conditions, tolerability, and your doctor's clinical judgment.
Why Ontario Patients Choose TelePlus Care for Trulicity
TelePlus Care gives adults with type 2 diabetes across Ontario timely, evidence-based access to guideline-recommended therapy without long waits for an in-person appointment. Our doctors include a licensed doctor who follows Diabetes Canada guidance. We don't dispense medication — we issue prescriptions you fill at any pharmacy in the province, whether that's a Shoppers Drug Mart in downtown Toronto, a Rexall in Ottawa, a Loblaw or Sobeys pharmacy in Hamilton or London, or a Costco pharmacy in the suburbs. Virtual visits reach urban and rural communities alike. Your intake helps the clinician understand your symptoms, history, and goals before the visit.
Your Fast and Convenient Healthcare Solution
Connect with a licensed healthcare provider from the comfort of your home. No referral needed — book your virtual appointment today.
Book Your Appointment Now
Other Ontario Locations
We also provide this service in these Ontario communities:
Teleplus care clinic is not an urgent care clinic. If you have an emergency please call911 or go to the nearest urgent care facility.
